Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Actavis and its Forced Switch Could Cost Medicare $288M This Year: Study
Actavis and its Forced Switch Could Cost Medicare $288M This Year: Study
Actavis and its Forced Switch Could Cost Medicare $288M This Year: Study
Submitted by
admin
on May 7, 2015 - 11:06am
Source:
WSJ Pharmalot
News Tags:
Actavis
Namenda XR
Alzheimer's disease
Medicare
Headline:
Actavis and its Forced Switch Could Cost Medicare $288M This Year: Study
Do Not Allow Advertisers to Use My Personal information
